{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:48:53Z","timestamp":1777304933295,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L232124"],"award-info":[{"award-number":["L232124"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-2-4014"],"award-info":[{"award-number":["2024-2-4014"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62476288"],"award-info":[{"award-number":["62476288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Clinical Specialty Construction Project","award":["U114000"],"award-info":[{"award-number":["U114000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04849-9","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:04:04Z","timestamp":1761570244000},"page":"1661-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin use linked to decreased risk of pelvic organ prolapse: insights from NHANES data"],"prefix":"10.1007","volume":"58","author":[{"given":"Zhe","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linru","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"1","key":"4849_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","volume":"175","author":"RC Bump","year":"1996","unstructured":"Bump RC, Mattiasson A, B\u00f8 K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175(1):10\u201317","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"4849_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/AOG.0000000000002016","volume":"129","author":"Practice Bulletin No","year":"2017","unstructured":"Practice Bulletin No (2017) 176: pelvic organ prolapse. Obstet Gynecol 129(4):e56\u2013e72","journal-title":"Obstet Gynecol"},{"key":"4849_CR3","doi-asserted-by":"crossref","unstructured":"Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD (2014) Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol 123(1):141\u2013148.","DOI":"10.1097\/AOG.0000000000000057"},{"key":"4849_CR4","doi-asserted-by":"crossref","unstructured":"Wu JM, Hundley AF, Fulton RG, Myers ER (2009) Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol 114(6):1278\u20131283.","DOI":"10.1097\/AOG.0b013e3181c2ce96"},{"key":"4849_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3853","volume":"354","author":"MD Barber","year":"2016","unstructured":"Barber MD (2016) Pelvic organ prolapse. BMJ 354:i3853","journal-title":"BMJ"},{"issue":"1","key":"4849_CR6","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1007\/s00192-006-0102-1","volume":"17","author":"HP Drutz","year":"2006","unstructured":"Drutz HP, Alarab M (2006) Pelvic organ prolapse: demographics and future growth prospects. Int Urogynecol J Pelvic Floor Dysfunct 17(1):S6-9","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"3","key":"4849_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/01.AOG.0000136100.10818.d8","volume":"104","author":"I Nygaard","year":"2004","unstructured":"Nygaard I, Bradley C, Brandt D (2004) Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 104(3):489\u2013497","journal-title":"Obstet Gynecol"},{"issue":"8","key":"4849_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00192-008-0591-1","volume":"19","author":"MT McLennan","year":"2008","unstructured":"McLennan MT, Harris JK, Kariuki B, Meyer S (2008) Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 19(8):1063\u20131069","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"5","key":"4849_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/nau.24672","volume":"40","author":"T Mou","year":"2021","unstructured":"Mou T, Warner K, Brown O, Yeh C, Beestrum M, Kenton K, Emi Bretschneider C (2021) Prevalence of pelvic organ prolapse among US racial populations: a systematic review and meta-analysis of population-based screening studies. Neurourol Urodyn 40(5):1098\u20131106","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"4849_CR10","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00192-023-05569-3","volume":"34","author":"FF Fitz","year":"2023","unstructured":"Fitz FF, Bortolini MAT, Pereira GMV, Salerno GRF, Castro RA (2023) PEOPLE: lifestyle and comorbidities as risk factors for pelvic organ prolapse-a systematic review and meta-analysis PEOPLE: PElvic Organ Prolapse Lifestyle comorbiditiEs. Int Urogynecol J 34(9):2007\u20132032","journal-title":"Int Urogynecol J"},{"issue":"11","key":"4849_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/gme.0b013e31826d2d94","volume":"19","author":"J Awwad","year":"2012","unstructured":"Awwad J, Sayegh R, Yeretzian J, Deeb ME (2012) Prevalence, risk factors, and predictors of pelvic organ prolapse: a community-based study. Menopause 19(11):1235\u20131241","journal-title":"Menopause"},{"key":"4849_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12894-015-0062-1","volume":"15","author":"HM Elbiss","year":"2015","unstructured":"Elbiss HM, Osman N, Hammad FT (2015) Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women. BMC Urol 15:66","journal-title":"BMC Urol"},{"issue":"7","key":"4849_CR13","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/nau.24447","volume":"39","author":"NC Batista","year":"2020","unstructured":"Batista NC, Bortolini MAT, Silva RSP, Teixeira JB, Melo NC, Santos RGM, Pepicelli FAA, Castro RA (2020) Collagen I and collagen III polymorphisms in women with pelvic organ prolapse. Neurourol Urodyn 39(7):1977\u20131984","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"4849_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/AOG.0b013e3181bf9cc8","volume":"114","author":"EL Whitcomb","year":"2009","unstructured":"Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK, Subak LL (2009) Racial differences in pelvic organ prolapse. Obstet Gynecol 114(6):1271\u20131277","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4849_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jgyn.2013.10.011","volume":"43","author":"E Bohoussou","year":"2014","unstructured":"Bohoussou E, Adjoussou SA, Letouzey V, Fatton B, de Tayrac R (2014) Should we perform intra-operative endometrial biopsy during pelvic reconstructive surgery with uterine preservation? J Gynecol Obstet Biol Reprod (Paris) 43(1):40\u201345","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"5","key":"4849_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/SPV.0b013e3181ed3e31","volume":"16","author":"G Rortveit","year":"2010","unstructured":"Rortveit G, Subak LL, Thom DH, Creasman JM, Vittinghoff E, Van Den Eeden SK, Brown JS (2010) Urinary incontinence, fecal incontinence and pelvic organ prolapse in a population-based, racially diverse cohort: prevalence and risk factors. Female Pelvic Med Reconstr Surg 16(5):278\u2013283","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"11","key":"4849_CR17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00192-018-3840-y","volume":"30","author":"G Gava","year":"2019","unstructured":"Gava G, Alvisi S, Mancini I, Seracchioli R, Meriggiola MC (2019) Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the pelvic organ prolapse quantification system. Int Urogynecol J 30(11):1911\u20131917","journal-title":"Int Urogynecol J"},{"issue":"4","key":"4849_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00192-014-2468-9","volume":"26","author":"A Rogowski","year":"2015","unstructured":"Rogowski A, Bienkowski P, Tarwacki D, Dziech E, Samochowiec J, Jerzak M, Baranowski W (2015) Association between metabolic syndrome and pelvic organ prolapse severity. Int Urogynecol J 26(4):563\u2013568","journal-title":"Int Urogynecol J"},{"key":"4849_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2015.11.035","volume":"197","author":"H Is\u0131k","year":"2016","unstructured":"Is\u0131k H, Ayn\u0131oglu O, Sahbaz A, Selimoglu R, Timur H, Harma M (2016) Are hypertension and diabetes mellitus risk factors for pelvic organ prolapse? Eur J Obstet Gynecol Reprod Biol 197:59\u201362","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"4849_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","volume":"8","author":"A Yerevanian","year":"2019","unstructured":"Yerevanian A, Soukas AA (2019) Metformin: mechanisms in human obesity and weight loss. Curr Obes Rep 8(2):156\u2013164","journal-title":"Curr Obes Rep"},{"issue":"1","key":"4849_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12916-024-03484-y","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Liu X, Lv W, Wang X, Du Z, Liu X, Meng F, Jin S, Wen S, Bai R et al (2024) Metformin use correlated with lower risk of cardiometabolic diseases and related mortality among US cancer survivors: evidence from a nationally representative cohort study. BMC Med 22(1):269","journal-title":"BMC Med"},{"issue":"1","key":"4849_CR22","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1080\/21655979.2021.1954581","volume":"12","author":"L Yang","year":"2021","unstructured":"Yang L, Yang J, Liang X, Huang W, Zhang X, Li R (2021) Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication. Bioengineered 12(1):4757\u20134767","journal-title":"Bioengineered"},{"key":"4849_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155223","volume":"133","author":"CR Triggle","year":"2022","unstructured":"Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, MacDonald R, Hollenberg MD, Hill MA (2022) Metformin: is it a drug for all reasons and diseases? Metabolism 133:155223","journal-title":"Metabolism"},{"issue":"3","key":"4849_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/1753-0407.12302","volume":"8","author":"SK Paul","year":"2016","unstructured":"Paul SK, Klein K, Majeed A, Khunti K (2016) Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes. J Diabetes 8(3):354\u2013362","journal-title":"J Diabetes"},{"key":"4849_CR25","doi-asserted-by":"publisher","first-page":"1526709","DOI":"10.3389\/fphar.2025.1526709","volume":"16","author":"P Nie","year":"2025","unstructured":"Nie P, Wang M, Mo Y, Zhou H, Zha Q, Lash GE, Li P (2025) Metformin in gynecological disorders: pathogenic insights and therapeutic implications. Front Pharmacol 16:1526709","journal-title":"Front Pharmacol"},{"issue":"1","key":"4849_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","volume":"97","author":"AJ Duleba","year":"2012","unstructured":"Duleba AJ, Dokras A (2012) Is PCOS an inflammatory process? Fertil Steril 97(1):7\u201312","journal-title":"Fertil Steril"},{"key":"4849_CR27","doi-asserted-by":"publisher","unstructured":"Kluivers KB, Lince SL, Ruiz-Zapata AM, Post WM, Cartwright R, Kerkhof MH, Widomska J, De Witte W, Pecanka J, Kiemeney LA et al (2023) Molecular landscape of pelvic organ prolapse provides insights into disease etiology. Int J Mol Sci 24(7). https:\/\/doi.org\/10.3390\/ijms24076087","DOI":"10.3390\/ijms24076087"},{"key":"4849_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123939","volume":"380","author":"Y Yan","year":"2025","unstructured":"Yan Y, Peng J, He W, Chen Y, Ye W, Yin Z, Cao Y (2025) SGK1 inhibits oxidative injury and extracellular matrix degradation by activating the GSK-3\u03b2 (Ser9)\/Fyn\/NRF2 pathway in pelvic organ prolapse. Life Sci 380:123939","journal-title":"Life Sci"},{"key":"4849_CR29","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.930433","volume":"27","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xia Z, Lin T, Qin M (2021) Transforming growth factor beta 1 and p44\/42 expression in cardinal ligament tissues of patients with pelvic organ prolapse. Med Sci Monit 27:e930433","journal-title":"Med Sci Monit"},{"issue":"11","key":"4849_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","volume":"41","author":"L He","year":"2020","unstructured":"He L (2020) Metformin and systemic metabolism. Trends Pharmacol Sci 41(11):868\u2013881","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"4849_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/SPV.0000000000000493","volume":"24","author":"OO Cardenas-Trowers","year":"2018","unstructured":"Cardenas-Trowers OO, Borgstrom M, Addis I (2018) Associations between type and route of hormone use on urinary incontinence and pelvic organ prolapse in premenopausal and postmenopausal women. Female Pelvic Med Reconstr Surg 24(2):100\u2013104","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"6","key":"4849_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1067\/mob.2001.118659","volume":"185","author":"MD Barber","year":"2001","unstructured":"Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185(6):1388\u20131395","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"4849_CR33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jama.300.11.1311","volume":"300","author":"I Nygaard","year":"2008","unstructured":"Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300(11):1311\u20131316","journal-title":"JAMA"},{"key":"4849_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108939","volume":"178","author":"SS Casagrande","year":"2021","unstructured":"Casagrande SS, Lee C, Stoeckel LE, Menke A, Cowie CC (2021) Cognitive function among older adults with diabetes and prediabetes, NHANES 2011\u20132014. Diabetes Res Clin Pract 178:108939","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"4849_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7326\/M13-2411","volume":"160","author":"E Selvin","year":"2014","unstructured":"Selvin E, Parrinello CM, Sacks DB, Coresh J (2014) Trends in prevalence and control of diabetes in the United States, 1988\u20131994 and 1999\u20132010. Ann Intern Med 160(8):517\u2013525","journal-title":"Ann Intern Med"},{"issue":"1","key":"4849_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11606-019-05398-5","volume":"35","author":"C Liu","year":"2020","unstructured":"Liu C, Foti K, Grams ME, Shin JI, Selvin E (2020) Trends in self-reported prediabetes and metformin use in the USA: NHANES 2005\u20132014. J Gen Intern Med 35(1):95\u2013101","journal-title":"J Gen Intern Med"},{"key":"4849_CR37","doi-asserted-by":"crossref","unstructured":"Standards of medical care in diabetes--2013 (2013) Diabetes Care, 36 Suppl 1(Suppl 1):S11\u201366.","DOI":"10.2337\/dc13-S011"},{"issue":"1","key":"4849_CR38","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1038\/s41598-024-63448-3","volume":"14","author":"B Wei","year":"2024","unstructured":"Wei B, Zhao Y, Lin P, Qiu W, Wang S, Gu C, Deng L, Deng T, Li S (2024) The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. Sci Rep 14(1):12579","journal-title":"Sci Rep"},{"key":"4849_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.110361","volume":"196","author":"OE Omoike","year":"2021","unstructured":"Omoike OE, Pack RP, Mamudu HM, Liu Y, Strasser S, Zheng S, Okoro J, Wang L (2021) Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress. Environ Res 196:110361","journal-title":"Environ Res"},{"key":"4849_CR40","doi-asserted-by":"publisher","unstructured":"Liu W, Wang J, Wang M, Hou H, Ding X, Ma L, Liu M (2024) Oxidative stress factors mediate the association between life\u2019s essential 8 and accelerated phenotypic aging: NHANES 2005\u20132018. J Gerontol A Biol Sci Med Sci, 79(1). https:\/\/doi.org\/10.1093\/gerona\/glad240","DOI":"10.1093\/gerona\/glad240"},{"issue":"2","key":"4849_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/SPV.0000000000000661","volume":"25","author":"O Cardenas-Trowers","year":"2019","unstructured":"Cardenas-Trowers O, Meyer I, Richter HE, Addis I, Markland AD (2019) Association of urinary phytoestrogens with pelvic organ prolapse and fecal incontinence symptoms in postmenopausal women. Female Pelvic Med Reconstr Surg 25(2):161\u2013166","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"8","key":"4849_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271467","volume":"17","author":"D Habes","year":"2022","unstructured":"Habes D, Kestranek J, Stranik J, Kacerovsky M, Spacek J (2022) Is there an association between pelvic organ prolapse and oxidative stress? A systematic review. PLoS ONE 17(8):e0271467","journal-title":"PLoS ONE"},{"issue":"1","key":"4849_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s10020-024-00989-3","volume":"30","author":"Y Chen","year":"2024","unstructured":"Chen Y, Ullah A, Chen W, Xuan J, Huang X, Liang S, Shen B, Wu T (2024) Cytokine modulation in pelvic organ prolapse and urinary incontinence: from molecular insights to therapeutic targets. Mol Med 30(1):214","journal-title":"Mol Med"},{"key":"4849_CR44","doi-asserted-by":"publisher","unstructured":"Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP (2019) Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol 70(6). https:\/\/doi.org\/10.26402\/jpp.2019.6.01","DOI":"10.26402\/jpp.2019.6.01"},{"key":"4849_CR45","doi-asserted-by":"publisher","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhao L, Zhou X, Meng X, Zhou X (2022) Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front Immunol 13:1098725","journal-title":"Front Immunol"},{"key":"4849_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108365","volume":"787","author":"AW Caliri","year":"2021","unstructured":"Caliri AW, Tommasi S, Besaratinia A (2021) Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutat Res 787:108365","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"5","key":"4849_CR47","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","volume":"119","author":"AR Cameron","year":"2016","unstructured":"Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK et al (2016) Anti-inflammatory effects of metformin irrespective of diabetes status. Circ Res 119(5):652\u2013665","journal-title":"Circ Res"},{"issue":"3","key":"4849_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","volume":"38","author":"MC Calle","year":"2012","unstructured":"Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab 38(3):183\u2013191","journal-title":"Diabetes Metab"},{"key":"4849_CR49","doi-asserted-by":"publisher","unstructured":"Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ et al (2014) Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst 106(11). https:\/\/doi.org\/10.1093\/jnci\/dju294","DOI":"10.1093\/jnci\/dju294"},{"key":"4849_CR50","doi-asserted-by":"publisher","unstructured":"Kiefer ZE, Studer JM, Chipman AL, Adur MK, Mainquist-Whigham C, Gabler NK, Keating AF, Ross JW (2021) Circulating biomarkers associated with pelvic organ prolapse risk in late gestation sows. J Anim Sci 99(8). https:\/\/doi.org\/10.1093\/jas\/skab207","DOI":"10.1093\/jas\/skab207"},{"issue":"1\u20133","key":"4849_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2010.11.029","volume":"653","author":"TM Louro","year":"2011","unstructured":"Louro TM, Matafome PN, Nunes EC, da Cunha FX, Sei\u00e7a RM (2011) Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats. Eur J Pharmacol 653(1\u20133):89\u201394","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"4849_CR52","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1177\/1060028020985303","volume":"55","author":"A Karbalaee-Hasani","year":"2021","unstructured":"Karbalaee-Hasani A, Khadive T, Eskandari M, Shahidi S, Mosavi M, Nejadebrahimi Z, Khalkhali L, Sangdari A, Mohammadi D, Soltani A et al (2021) Effect of metformin on circulating levels of inflammatory markers in patients with Type 2 Diabetes: a systematic review and meta-analysis of randomized controlled trials. Ann Pharmacother 55(9):1096\u20131109","journal-title":"Ann Pharmacother"},{"key":"4849_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726490","volume":"12","author":"M Gharib","year":"2021","unstructured":"Gharib M, Elbaz W, Darweesh E, Sabri NA, Shawki MA (2021) Efficacy and safety of metformin use in rheumatoid arthritis: a randomized controlled study. Front Pharmacol 12:726490","journal-title":"Front Pharmacol"},{"issue":"8","key":"4849_CR54","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/dc13-2471","volume":"37","author":"RB Goldberg","year":"2014","unstructured":"Goldberg RB, Temprosa MG, Mather KJ, Orchard TJ, Kitabchi AE, Watson KE (2014) Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes. Diabetes Care 37(8):2253\u20132260","journal-title":"Diabetes Care"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04849-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04849-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04849-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:02:41Z","timestamp":1777302161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04849-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4849"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04849-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The National Centre for Health Statistics Ethics Review Committee granted ethics approval from the NHANES (Protocol No. 2005\u201306 for the 2005\u20132010 cycles, Protocol No. 2011\u201317 for the 2011\u20132016 cycles), as detailed on their official site (\n                      \n                      ). The NHANES provides open-access data for public use. The analysis in our study is a secondary analysis of NHANES data. Secondary analyses of publicly accessible de-identified datasets are exempt from review by the Research Ethics Committee at our institution (the ethics committees of Peking Union Medical College Hospital). All individuals signed written informed consent before participating in the NHANES study. This study and its methodology are based on the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}